Funding Tracker/NeuroXess
Series B · Devices & Robotics · China
NeuroXess raises CNY 700M (USD undisclosed)
Announced October 28, 2026
The round
NeuroXess announced a Series B round of CNY 700M (USD undisclosed) on October 28, 2026, led by SDIC Unity Capital, Shenzhen Capital Group, Triwise Capital. Other participants include China Fortune-Tech Capital, Huangpu Investment, Cornerstone Capital, IDG Capital, Xichen Capital, Junxi Capital, Huafu Securities, Huasai Zhihui, ZWC Partners, Jiangxi Financial Holding, Shanda Group, Zhongping Capital.
The SignalThe company announced RMB 700 million, not a US-dollar amount. Named co-leads and participants come from its announcement. Proceeds support registered clinical trials and regulatory approvals for the implantable Triple-F BCI system, manufacturing and research. The system remains under clinical development.
- Company
- NeuroXess
- Amount
- CNY 700M (USD undisclosed)
- Stage
- Series B
- Announced
- October 28, 2026
- Led by
- SDIC Unity Capital, Shenzhen Capital Group, Triwise Capital
- Other investors
- China Fortune-Tech Capital, Huangpu Investment, Cornerstone Capital, IDG Capital, Xichen Capital, Junxi Capital, Huafu Securities, Huasai Zhihui, ZWC Partners, Jiangxi Financial Holding, Shanda Group, Zhongping Capital
- Vertical
- Devices & Robotics
- Country
- China